gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

Immunogenic properties of cultured human nucleus pulposus cells for regenerative treatment approaches

Meeting Abstract

  • Aldemar Andres Hegewald - Klinik für Neurochirurgie, Universitätsmedizin Mannheim, Universität Heidelberg
  • Stefan Stich - Labor für Tissue Engineering und Berlin-Brandenburg Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin
  • Meaghan Stolk - Institut für Medizinische Immunologie und Berlin-Brandenburg Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin
  • Michael Sittinger - Labor für Tissue Engineering und Berlin-Brandenburg Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin
  • Jochen Ringe - Labor für Tissue Engineering und Berlin-Brandenburg Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin
  • Martina Seifert - Institut für Medizinische Immunologie und Berlin-Brandenburg Centrum für Regenerative Therapien, Charité – Universitätsmedizin Berlin

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocDI.12.04

doi: 10.3205/14dgnc185, urn:nbn:de:0183-14dgnc1855

Veröffentlicht: 13. Mai 2014

© 2014 Hegewald et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Cell-based regenerative approaches have been suggested for the treatment of intervertebral disc (IVD) diseases. Alterations of immunogenic properties along IVD cell isolation and expansion and in 3D culture with various biomaterials, however, have been scarcely addressed. Therefore, our aim was to evaluate the immunogenic properties of mild and severely degenerated nucleus pulposus (NP) cells with regard to cell surface markers and co-cultures with autologous or allogenic peripheral blood mononuclear cells (PBMC) as well as changes of theses immunogenic properties after 3D culture.

Method: Ten patients with severe and mild grades of IVD degeneration were included. NP cells were isolated, expanded and cultured in 3D fibrin/PLGA transplants. NP cells were evaluated for induction of immune responses in co-culture with PBMC from the same donor or from an allogenic donor, using a 5,6-carboxyfluorescein diacetate N-succinimidyl ester-based proliferation assay. Surface marker detection and evaluation of cytokines was performed by Cytometric Bead Array and FACS analysis.

Results: All cells expressed HLA-ABC and CD95 (Fas), but lacked expression of HLA-DR and CD24. NP cells after monolayer culture did not provoke a significant proliferation of T cells, NK cells or B cells from either the same donor or from allogenic PBMC. NP cells in a 3D matrix, however, provoked the immune cell proliferation to a greater extent than in monolayer culture. 3D specimens containing NP cells from patients with severe degeneration tended to provoke a larger response, especially for CD3+CD8+ and CD3+CD4+ T cells, than those with mild degeneration. In general, the cytokine release was low, especially for the inflammatory cytokines TNF-alpha and IFN-gamma.

Conclusions: NP cells in monolayer, regardless of their grade of degeneration, did not provoke a significant proliferation response in T cells, NK cells or B cells. In conjunction with low inflammatory cytokine expression, a low immunogenicity can be assumed, facilitating possible therapeutic approaches. In 3D culture, however, we found higher immune cell proliferation levels. This emphasizes the importance of considering specific immunological alterations when including biomaterials into a therapeutic concept. The overall expression of Fas receptor on cultured NP cells could have disadvantageous implications on their potential therapeutic applications because of cytotoxic T-cell activity acting by Fas ligand-induced apoptosis.